A RANDOMIZED OPEN LABELLED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF ASHTANGA GHRITA IN THE MANAGEMENT OF CHITTODVEGA WITH SPECIAL REFERENCE TO GENERALIZED ANXIETY DISORDER.

Dr TARA B0 个研究点目标入组 40 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1.SUBJECTS SUFFERING FROM GENERALIZED ANXIETY DISORDER BETWEEN AGE GROUP OF 20 TO 60 YEARS IRRESPECTIVE OF GENDER SOCIO ECONOMIC STATUS AND RELIGION. 2.SUBJECTS PRESENTING WITH PROMINENT TENSION WORRY AND FEELINGS OF APPREHENSION ABOUT EVERY-DAY EVENTS AND PROBLEMS FOR A MINIMUM PERIOD OF AT LEAST SIX MONTHS. 3.SUBJECTS FULFILLING CRITERIA BASED ON ICD 10 F41 1 CLASSIFICATION OF MENTAL AND BEHAVIOURAL DISORDERS CODE F41 1 AND THOSE GET SCORE BETWEEN 14-24 IN HAMILTON ANXIETY RATING SCALE MILD 14-17 AND MODERATE 18-24 WILL BE INCLUDED IN THE STUDY.

•1. SUBJECTS SUFFERING FROM PANIC DISORDER F41 PHOBIC ANXIETY DISORDERS F40
•OBSESSIVE-COMPULSIVE DISORDER F42 AND HYPOCHONDRIACAL DISORDER F45 2
•2. SUBJECTS SUFFERING FROM OTHER PSYCHIATRIC ILLNESSES LIKE MOOD DISORDER, PSYCHOSIS,
•3. SUBJECTS SUFFERING FROM GENERALIZED ANXIETY DISORDER ASSOCIATED WITH OTHER SERIOUS
•ILLNESSES THAT WOULD INTERFERE WITH THE TREATMENT.
•4. SUBJECTS SUFFERING FROM HYPERTHYROIDISM, ORGANIC MENTAL DISORDER OR PSYCHOACTIVE
•SUBSTANCE-RELATED DISORDER F1 SUCH AS EXCESS CONSUMPTION OF AMPHETAMINE-LIKE
•SUBSTANCES, OR WITHDRAWAL FROM BENZODIAZEPINES.
•5. SUBJECTS WHO ARE ALREADY TAKING ALLOPATHIC MEDICATION FOR GENERALISED ANXIETY
•6. PREGNANT AND LACTATING MOTHERS.

发起方

Dr TARA B